Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$206.39 - $268.73 $825 - $1,074
-4 Reduced 0.2%
2,021 $417,000
Q1 2024

May 03, 2024

SELL
$203.52 - $273.43 $149,790 - $201,244
-736 Reduced 26.66%
2,025 $548,000
Q3 2023

Nov 02, 2023

BUY
$194.44 - $217.61 $10,305 - $11,533
53 Added 1.96%
2,761 $541,000
Q1 2023

May 04, 2023

BUY
$191.89 - $259.92 $10,937 - $14,815
57 Added 2.15%
2,708 $546,000
Q4 2022

Feb 06, 2023

BUY
$197.11 - $250.07 $985 - $1,250
5 Added 0.19%
2,651 $577,000
Q3 2022

Nov 07, 2022

BUY
$182.44 - $250.54 $482,736 - $662,928
2,646 New
2,646 $521,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Lmcg Investments, LLC Portfolio

Follow Lmcg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmcg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lmcg Investments, LLC with notifications on news.